ContractClinical Trial Agreement • November 13th, 2023
Contract Type FiledNovember 13th, 2023AMENTMENT # 1 TO THE CLINICAL TRIAL AGREEMENT PROTOCOL # 64007957MMY3006 DODATEK 1 KE SMLOUVĚ O KLINICKÉM HODNOCENÍPROTOKOL # 64007957MMY3006 This Amendment #1 (“Amendment”) to the Clinical Trial Agreement (“Agreement”) shall enter into effect on the day of ist publication in the contracts register (“Effective Date”) Between Tento dodatek číslo 1 (“Dodatek”) ke smlouvěo klinickém hodnocení („smlouva“) nabývá účinnosti dnem jeho uveřejnění v registru smluv(„datum účinnosti“)Uzavřený mezi Janssen – Cilag International N.V.,with registered offices at: Turnhoutseweg 30, 2340 Beerse, BelgiumRegistration No.: BE0461607459Represented by the Power of Attorney by the companyJanssen-Cilag s.r.o.with registered offices at Walterovo náměstí 329/1, 158 00 Praha 5 – Jinonice, Czech RepublicID No.: 27146928 Tax ID: CZ27146928Registered in the Commercial Register at the Municipal Court in Prague, section C, enclosure 99837Bank details: Citibank Europe plc, OrganizationalUnitAccount number: 2043060205/